RE:RE:RE:RE:Scientific Panel - 6 DocsGet used to it GiGiGi. The reason we are all anticipating solid, fundamental, altering news about doing a Phase 3 in NASh and a Phase 1 in oncology. Biotechs need solid future developments under their belt with approvals as catalytic events that get them to the next level. News will flow with those trials and open up much larger markets. That's how you create value. But we need to get there. Right now it's an ignored microcap where $200,000 can move it 10%. That's not a serious investment case for larger guys. It will come if they execute positively, but that's the wait.
Buckle your seatbelt and be patient GiGi.
ggg088 wrote: most people is disappointed with this stock , down 3% when market up.